Salesforce.com to B...
Health Care: Health Services
CAS Medical Systems Inc. (CASM: NASDAQ)
$1.92 0.00 | 0.00%
06/04/12 - 09:30 AM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 15.40 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 49.90 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 15.50 | 12.50 |
| Beta | 0.35 | 0.77 | 0.98 |
| Price to Sales (TTM) | 1.18 | 1.97 | 1.42 |
| Price to Book (MRQ) | 7.65 | 2.14 | 2.41 |
| Price to Tangible Book (MRQ) | 9.54 | 7.49 | 5.08 |
| Price to Cash Flow (TTM) | -3.80 | 10.50 | 9.80 |
| Price to Free Cash Flow (TTM) | -5.90 | 58.60 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 1.10 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 1.00 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 8.98 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 17.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | -4.20 | 10.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -6.80 | -11.40 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | -11.23 | 12.06 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 8.70 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 8.70 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -10.33 | 6.33 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 5.00 | 1.80 | 1.10 |
| Current Ratio (MRQ) | 6.30 | 2.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.32 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.34 | 0.96 |
| Interest Coverage (TTM) | n.a. | 11.50 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 42.10 | 59.90 | 46.90 |
| Gross Margin - 5 Yr Avg | 38.50 | 59.90 | 47.70 |
| EBITD Margin (TTM) | -28.00 | 23.80 | 18.90 |
| EBITD - 5 Yr Avg | 1.38 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -32.10 | 15.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | -8.80 | 11.90 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -0.32 | 0.13 | 0.09 |
| Net Profit Margin - 5 Yr Avg | -8.30 | 8.70 | 7.00 |
| Return on Assets (TTM) | -32.20 | 7.60 | 3.10 |
| Return on Assets - 5 Yr Avg | -12.80 | 5.20 | 2.50 |
| Return on Investment (TTM) | -39.00 | 10.20 | 7.90 |
| Return on Investment - 5 Yr Avg | -18.30 | 7.20 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 207,629.00 | 296,359.00 | 449,376.00 |
| Net Income/Employee (TTM) | -63,768.00 | 40,294.00 | 39,003.00 |
| Receivable Turnover (TTM) | 7.30 | 6.00 | 7.60 |
| Inventory Turnover (TTM) | 3.10 | 2.90 | 8.30 |
| Asset Turnover (TTM) | 1.30 | 0.60 | 0.40 |
Portfolios with CASM
- Portfolio NameUser Type
- UserAshley
- ContributorUnder-$10 Setting Up To Tra...
- Contributor26 Small-Cap Stocks in Dang...
- Contributor8 Health Care Penny Stocks ...
- Usermsi Portfolio 1
- UserJane's SEP
- Userleon16066 Portfolio 1
- UserAdam Portfolio 1
Latest CASM Headlines from TheStreet
- 5 Stocks Under $10 Poised to Move Higher 04.05.12 | 01:04 pm
- CASMED Reports Fourth Quarter And Full Year 2010 Results 03.02.11 | 08:03 am
- CASMED Announces Fourth Quarter And Year-End 2010 Earnings Release Date And Conference Call Information 02.23.11 | 08:02 am
- CASMED Receives FDA Clearance For Non-Cerebral Indication Of FORE-SIGHT Absolute Tissue Oximeter 01.18.11 | 08:01 am
- CASMED Reports Inducement Grants To VP Of Sales And Marketing Matthew J. Herwig Under NASDAQ Marketplace Rule 5635 01.10.11 | 10:01 am
- CASMED Announces Key Addition To Executive Management Team 01.10.11 | 08:01 am
- CASMED Reports Third Quarter 2010 Results 11.10.10 | 04:11 pm
- CASMED Announces Third Quarter 2010 Earnings Release Date And Conference Call Information 11.03.10 | 08:11 am
- Gregory Rainey Appointed To CASMED Board 11.01.10 | 03:11 pm
- CASMED Announces 9 Scientific Abstracts Demonstrating The Benefits Of FORE-SIGHT Absolute Oximetry 10.21.10 | 08:10 am
Press Releases for CASM
Partner Headlines for CASM
- CASMED Reports Third Quarter EPS of $(0.04) - Benzinga 11.10.10 | 04:11 pm
- UPDATE 1-CAS Medical gets new Japanese patent, shares jump - Reuters 04.13.10 | 10:04 am
